Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Roivant Sciences Ltd., 3 years.
Roivant Sciences Ltd.
Director
BridgeBio Pharma Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 17, 2026 | Roivant Sciences Ltd. | Grant or award | +405 | — | — |
| Jun 22, 2026 | BridgeBio Pharma Inc. | Grant or award | +3,990 | — | — |
| Apr 17, 2026 | Roivant Sciences Ltd. | Grant or award | +469 | — | — |
| Apr 17, 2026 | Roivant Sciences Ltd. | Shares withheld for tax | −94 | $29.83 | $2,804 |
| Jan 20, 2026 | Roivant Sciences Ltd. | Grant or award | +609 | — | — |
| Jan 20, 2026 | Roivant Sciences Ltd. | Shares withheld for tax | −122 | $22.98 | $2,804 |
| Oct 20, 2025 | Roivant Sciences Ltd. | Grant or award | +789 | — | — |
| Oct 20, 2025 | Roivant Sciences Ltd. | Shares withheld for tax | −158 | $17.74 | $2,803 |
| Sep 10, 2025 | Roivant Sciences Ltd. | Grant or award | +14,524 | — | — |
| Sep 10, 2025 | Roivant Sciences Ltd. | Other | −3,282 | $13.77 | $45,193 |
| Jul 17, 2025 | Roivant Sciences Ltd. | Grant or award | +1,201 | — | — |
| Jul 17, 2025 | Roivant Sciences Ltd. | Shares withheld for tax | −241 | $11.65 | $2,808 |
| Jun 20, 2025 | BridgeBio Pharma Inc. | Grant or award | +6,589 | — | — |
| Apr 17, 2025 | Roivant Sciences Ltd. | Grant or award | +1,379 | — | — |
| Apr 17, 2025 | Roivant Sciences Ltd. | Shares withheld for tax | −276 | $10.15 | $2,801 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.